ArthroCare (Austin, Texas) shares may be trading less on fundamentals and more on the firm's take-out potential, according to Canaccord Genuity (Toronto) analyst William Plovanic. The med-tech analyst penned his thoughts regarding ArthroCare as a take-out target in a 13-page report released Tuesday.
Until recently the law regulating patients' healthcare privacy, the Health Insurance Portability and Accountability Act (HIPAA) of 1996, was believed to be something that primarily pertained to hospitals or other healthcare facilities dealing directly with patients. But the adoption of electronic health records and cloud computing services has changed the way patient healthcare information is updated and who has access to that information.
St. Jude Medical (St. Paul, Minnesota) said it has received FDA approval to begin the EnligHTN IV renal denervation study, the first U.S. trial using the EnligHTN multi-electrode renal denervation system to treat patients with drug-resistant high blood pressure.
DiagnoCure (Quebec City) reported that results of a new study presented during the American Society of Clinical Oncology (ASCO; Alexandria, Virginia) meeting in Chicago provides strong evidence that its Guanylyl cyclase C (GCC) assay is able to predict colon cancer recurrence. The study was presented by Daniel Sargent, PhD, professor of biostatistics and oncology at Mayo Clinic (Rochester, Minnesota) and colleagues.
